nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2D6—Alzheimer's disease	0.295	1	CbGaD
Carbinoxamine—CYP2B6—Memantine—Alzheimer's disease	0.112	0.205	CbGbCtD
Carbinoxamine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0784	0.143	CbGbCtD
Carbinoxamine—CYP2C19—Memantine—Alzheimer's disease	0.0714	0.13	CbGbCtD
Carbinoxamine—CYP2C9—Donepezil—Alzheimer's disease	0.0685	0.125	CbGbCtD
Carbinoxamine—CYP2D6—Donepezil—Alzheimer's disease	0.0626	0.114	CbGbCtD
Carbinoxamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0498	0.0908	CbGbCtD
Carbinoxamine—CYP2D6—Galantamine—Alzheimer's disease	0.0404	0.0735	CbGbCtD
Carbinoxamine—CYP3A4—Donepezil—Alzheimer's disease	0.0398	0.0726	CbGbCtD
Carbinoxamine—CYP3A4—Galantamine—Alzheimer's disease	0.0257	0.0468	CbGbCtD
Carbinoxamine—Epigastric distress—Donepezil—Alzheimer's disease	0.00497	0.0424	CcSEcCtD
Carbinoxamine—Extrasystoles—Memantine—Alzheimer's disease	0.00208	0.0177	CcSEcCtD
Carbinoxamine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00203	0.0173	CcSEcCtD
Carbinoxamine—Wheezing—Donepezil—Alzheimer's disease	0.00187	0.016	CcSEcCtD
Carbinoxamine—Urinary retention—Galantamine—Alzheimer's disease	0.00172	0.0146	CcSEcCtD
Carbinoxamine—Euphoric mood—Donepezil—Alzheimer's disease	0.00165	0.0141	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00155	0.0132	CcSEcCtD
Carbinoxamine—Pollakiuria—Galantamine—Alzheimer's disease	0.00144	0.0123	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00136	0.0116	CcSEcCtD
Carbinoxamine—Irritability—Donepezil—Alzheimer's disease	0.00133	0.0114	CcSEcCtD
Carbinoxamine—Urinary retention—Donepezil—Alzheimer's disease	0.00133	0.0113	CcSEcCtD
Carbinoxamine—Diplopia—Memantine—Alzheimer's disease	0.00127	0.0108	CcSEcCtD
Carbinoxamine—Diplopia—Rivastigmine—Alzheimer's disease	0.00124	0.0106	CcSEcCtD
Carbinoxamine—Irritability—Memantine—Alzheimer's disease	0.00121	0.0103	CcSEcCtD
Carbinoxamine—Urinary retention—Memantine—Alzheimer's disease	0.00121	0.0103	CcSEcCtD
Carbinoxamine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00118	0.0101	CcSEcCtD
Carbinoxamine—Sweating increased—Donepezil—Alzheimer's disease	0.00118	0.01	CcSEcCtD
Carbinoxamine—Tinnitus—Galantamine—Alzheimer's disease	0.00116	0.00993	CcSEcCtD
Carbinoxamine—Pollakiuria—Donepezil—Alzheimer's disease	0.00112	0.00952	CcSEcCtD
Carbinoxamine—Sweating increased—Memantine—Alzheimer's disease	0.00107	0.00912	CcSEcCtD
Carbinoxamine—Tension—Galantamine—Alzheimer's disease	0.00107	0.00909	CcSEcCtD
Carbinoxamine—Nervousness—Galantamine—Alzheimer's disease	0.00105	0.009	CcSEcCtD
Carbinoxamine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00105	0.00892	CcSEcCtD
Carbinoxamine—Vision blurred—Galantamine—Alzheimer's disease	0.00102	0.00873	CcSEcCtD
Carbinoxamine—Tremor—Galantamine—Alzheimer's disease	0.00102	0.00868	CcSEcCtD
Carbinoxamine—Pollakiuria—Memantine—Alzheimer's disease	0.00101	0.00865	CcSEcCtD
Carbinoxamine—Agitation—Galantamine—Alzheimer's disease	0.000998	0.00852	CcSEcCtD
Carbinoxamine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000991	0.00846	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00098	0.00836	CcSEcCtD
Carbinoxamine—Vertigo—Galantamine—Alzheimer's disease	0.000976	0.00833	CcSEcCtD
Carbinoxamine—Palpitations—Galantamine—Alzheimer's disease	0.00096	0.00819	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000959	0.00818	CcSEcCtD
Carbinoxamine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000957	0.00816	CcSEcCtD
Carbinoxamine—Convulsion—Galantamine—Alzheimer's disease	0.000941	0.00803	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000938	0.008	CcSEcCtD
Carbinoxamine—Agranulocytosis—Memantine—Alzheimer's disease	0.000913	0.00779	CcSEcCtD
Carbinoxamine—Tinnitus—Donepezil—Alzheimer's disease	0.000902	0.00769	CcSEcCtD
Carbinoxamine—Confusional state—Galantamine—Alzheimer's disease	0.000894	0.00763	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000868	0.00741	CcSEcCtD
Carbinoxamine—Chills—Donepezil—Alzheimer's disease	0.000868	0.0074	CcSEcCtD
Carbinoxamine—Tachycardia—Galantamine—Alzheimer's disease	0.000865	0.00738	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000857	0.00731	CcSEcCtD
Carbinoxamine—Anorexia—Galantamine—Alzheimer's disease	0.000845	0.00721	CcSEcCtD
Carbinoxamine—Hypotension—Galantamine—Alzheimer's disease	0.000828	0.00707	CcSEcCtD
Carbinoxamine—Tension—Donepezil—Alzheimer's disease	0.000826	0.00705	CcSEcCtD
Carbinoxamine—Tinnitus—Memantine—Alzheimer's disease	0.000819	0.00698	CcSEcCtD
Carbinoxamine—Nervousness—Donepezil—Alzheimer's disease	0.000818	0.00698	CcSEcCtD
Carbinoxamine—Insomnia—Galantamine—Alzheimer's disease	0.000802	0.00684	CcSEcCtD
Carbinoxamine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000801	0.00683	CcSEcCtD
Carbinoxamine—Paraesthesia—Galantamine—Alzheimer's disease	0.000796	0.00679	CcSEcCtD
Carbinoxamine—Vision blurred—Donepezil—Alzheimer's disease	0.000793	0.00677	CcSEcCtD
Carbinoxamine—Tremor—Donepezil—Alzheimer's disease	0.000789	0.00673	CcSEcCtD
Carbinoxamine—Somnolence—Galantamine—Alzheimer's disease	0.000788	0.00672	CcSEcCtD
Carbinoxamine—Chills—Memantine—Alzheimer's disease	0.000788	0.00672	CcSEcCtD
Carbinoxamine—Dyspepsia—Galantamine—Alzheimer's disease	0.00078	0.00666	CcSEcCtD
Carbinoxamine—Agitation—Donepezil—Alzheimer's disease	0.000774	0.0066	CcSEcCtD
Carbinoxamine—Chills—Rivastigmine—Alzheimer's disease	0.000771	0.00658	CcSEcCtD
Carbinoxamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000771	0.00657	CcSEcCtD
Carbinoxamine—Fatigue—Galantamine—Alzheimer's disease	0.000764	0.00652	CcSEcCtD
Carbinoxamine—Constipation—Galantamine—Alzheimer's disease	0.000758	0.00647	CcSEcCtD
Carbinoxamine—Vertigo—Donepezil—Alzheimer's disease	0.000756	0.00645	CcSEcCtD
Carbinoxamine—Tension—Memantine—Alzheimer's disease	0.00075	0.0064	CcSEcCtD
Carbinoxamine—Nervousness—Memantine—Alzheimer's disease	0.000742	0.00633	CcSEcCtD
Carbinoxamine—Tension—Rivastigmine—Alzheimer's disease	0.000734	0.00626	CcSEcCtD
Carbinoxamine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000731	0.00623	CcSEcCtD
Carbinoxamine—Convulsion—Donepezil—Alzheimer's disease	0.000729	0.00622	CcSEcCtD
Carbinoxamine—Nervousness—Rivastigmine—Alzheimer's disease	0.000726	0.0062	CcSEcCtD
Carbinoxamine—Vision blurred—Memantine—Alzheimer's disease	0.00072	0.00615	CcSEcCtD
Carbinoxamine—Tremor—Memantine—Alzheimer's disease	0.000716	0.00611	CcSEcCtD
Carbinoxamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000705	0.00601	CcSEcCtD
Carbinoxamine—Agitation—Memantine—Alzheimer's disease	0.000702	0.00599	CcSEcCtD
Carbinoxamine—Tremor—Rivastigmine—Alzheimer's disease	0.000701	0.00598	CcSEcCtD
Carbinoxamine—Confusional state—Donepezil—Alzheimer's disease	0.000693	0.00591	CcSEcCtD
Carbinoxamine—Agitation—Rivastigmine—Alzheimer's disease	0.000687	0.00586	CcSEcCtD
Carbinoxamine—Vertigo—Memantine—Alzheimer's disease	0.000687	0.00586	CcSEcCtD
Carbinoxamine—Palpitations—Memantine—Alzheimer's disease	0.000675	0.00576	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000673	0.00574	CcSEcCtD
Carbinoxamine—Vertigo—Rivastigmine—Alzheimer's disease	0.000672	0.00573	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000664	0.00567	CcSEcCtD
Carbinoxamine—Convulsion—Memantine—Alzheimer's disease	0.000662	0.00565	CcSEcCtD
Carbinoxamine—Palpitations—Rivastigmine—Alzheimer's disease	0.000661	0.00564	CcSEcCtD
Carbinoxamine—Anorexia—Donepezil—Alzheimer's disease	0.000655	0.00559	CcSEcCtD
Carbinoxamine—Convulsion—Rivastigmine—Alzheimer's disease	0.000648	0.00553	CcSEcCtD
Carbinoxamine—Hypotension—Donepezil—Alzheimer's disease	0.000642	0.00548	CcSEcCtD
Carbinoxamine—Asthenia—Galantamine—Alzheimer's disease	0.000636	0.00543	CcSEcCtD
Carbinoxamine—Confusional state—Memantine—Alzheimer's disease	0.000629	0.00537	CcSEcCtD
Carbinoxamine—Insomnia—Donepezil—Alzheimer's disease	0.000621	0.0053	CcSEcCtD
Carbinoxamine—Paraesthesia—Donepezil—Alzheimer's disease	0.000617	0.00526	CcSEcCtD
Carbinoxamine—Confusional state—Rivastigmine—Alzheimer's disease	0.000615	0.00525	CcSEcCtD
Carbinoxamine—Somnolence—Donepezil—Alzheimer's disease	0.000611	0.00521	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000611	0.00521	CcSEcCtD
Carbinoxamine—Tachycardia—Memantine—Alzheimer's disease	0.000609	0.00519	CcSEcCtD
Carbinoxamine—Diarrhoea—Galantamine—Alzheimer's disease	0.000607	0.00518	CcSEcCtD
Carbinoxamine—Dyspepsia—Donepezil—Alzheimer's disease	0.000605	0.00516	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000603	0.00515	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000597	0.0051	CcSEcCtD
Carbinoxamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000597	0.0051	CcSEcCtD
Carbinoxamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000596	0.00508	CcSEcCtD
Carbinoxamine—Anorexia—Memantine—Alzheimer's disease	0.000595	0.00507	CcSEcCtD
Carbinoxamine—Fatigue—Donepezil—Alzheimer's disease	0.000592	0.00505	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00059	0.00503	CcSEcCtD
Carbinoxamine—Constipation—Donepezil—Alzheimer's disease	0.000587	0.00501	CcSEcCtD
Carbinoxamine—Dizziness—Galantamine—Alzheimer's disease	0.000586	0.005	CcSEcCtD
Carbinoxamine—Hypotension—Memantine—Alzheimer's disease	0.000583	0.00497	CcSEcCtD
Carbinoxamine—Anorexia—Rivastigmine—Alzheimer's disease	0.000582	0.00496	CcSEcCtD
Carbinoxamine—Hypotension—Rivastigmine—Alzheimer's disease	0.00057	0.00487	CcSEcCtD
Carbinoxamine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000566	0.00483	CcSEcCtD
Carbinoxamine—Insomnia—Memantine—Alzheimer's disease	0.000564	0.00481	CcSEcCtD
Carbinoxamine—Vomiting—Galantamine—Alzheimer's disease	0.000564	0.00481	CcSEcCtD
Carbinoxamine—Paraesthesia—Memantine—Alzheimer's disease	0.00056	0.00478	CcSEcCtD
Carbinoxamine—Headache—Galantamine—Alzheimer's disease	0.000555	0.00474	CcSEcCtD
Carbinoxamine—Somnolence—Memantine—Alzheimer's disease	0.000555	0.00473	CcSEcCtD
Carbinoxamine—Insomnia—Rivastigmine—Alzheimer's disease	0.000552	0.00471	CcSEcCtD
Carbinoxamine—Dyspepsia—Memantine—Alzheimer's disease	0.000549	0.00468	CcSEcCtD
Carbinoxamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000548	0.00468	CcSEcCtD
Carbinoxamine—Urticaria—Donepezil—Alzheimer's disease	0.000546	0.00466	CcSEcCtD
Carbinoxamine—Somnolence—Rivastigmine—Alzheimer's disease	0.000543	0.00463	CcSEcCtD
Carbinoxamine—Decreased appetite—Memantine—Alzheimer's disease	0.000542	0.00463	CcSEcCtD
Carbinoxamine—Fatigue—Memantine—Alzheimer's disease	0.000538	0.00459	CcSEcCtD
Carbinoxamine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000537	0.00458	CcSEcCtD
Carbinoxamine—Constipation—Memantine—Alzheimer's disease	0.000533	0.00455	CcSEcCtD
Carbinoxamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00053	0.00453	CcSEcCtD
Carbinoxamine—Nausea—Galantamine—Alzheimer's disease	0.000527	0.00449	CcSEcCtD
Carbinoxamine—Fatigue—Rivastigmine—Alzheimer's disease	0.000526	0.00449	CcSEcCtD
Carbinoxamine—Constipation—Rivastigmine—Alzheimer's disease	0.000522	0.00445	CcSEcCtD
Carbinoxamine—Feeling abnormal—Memantine—Alzheimer's disease	0.000514	0.00439	CcSEcCtD
Carbinoxamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000503	0.00429	CcSEcCtD
Carbinoxamine—Urticaria—Memantine—Alzheimer's disease	0.000496	0.00423	CcSEcCtD
Carbinoxamine—Asthenia—Donepezil—Alzheimer's disease	0.000493	0.00421	CcSEcCtD
Carbinoxamine—Urticaria—Rivastigmine—Alzheimer's disease	0.000485	0.00414	CcSEcCtD
Carbinoxamine—Diarrhoea—Donepezil—Alzheimer's disease	0.00047	0.00401	CcSEcCtD
Carbinoxamine—Dizziness—Donepezil—Alzheimer's disease	0.000454	0.00388	CcSEcCtD
Carbinoxamine—Asthenia—Memantine—Alzheimer's disease	0.000448	0.00382	CcSEcCtD
Carbinoxamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000438	0.00374	CcSEcCtD
Carbinoxamine—Vomiting—Donepezil—Alzheimer's disease	0.000437	0.00373	CcSEcCtD
Carbinoxamine—Headache—Donepezil—Alzheimer's disease	0.00043	0.00367	CcSEcCtD
Carbinoxamine—Diarrhoea—Memantine—Alzheimer's disease	0.000427	0.00364	CcSEcCtD
Carbinoxamine—Clomipramine—HTR6—Alzheimer's disease	0.000424	0.117	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR6—Alzheimer's disease	0.000422	0.117	CrCbGaD
Carbinoxamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000418	0.00356	CcSEcCtD
Carbinoxamine—Dizziness—Memantine—Alzheimer's disease	0.000412	0.00352	CcSEcCtD
Carbinoxamine—Nausea—Donepezil—Alzheimer's disease	0.000408	0.00348	CcSEcCtD
Carbinoxamine—Dizziness—Rivastigmine—Alzheimer's disease	0.000404	0.00344	CcSEcCtD
Carbinoxamine—Vomiting—Memantine—Alzheimer's disease	0.000397	0.00338	CcSEcCtD
Carbinoxamine—Headache—Memantine—Alzheimer's disease	0.000391	0.00333	CcSEcCtD
Carbinoxamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000388	0.00331	CcSEcCtD
Carbinoxamine—Headache—Rivastigmine—Alzheimer's disease	0.000382	0.00326	CcSEcCtD
Carbinoxamine—Nausea—Memantine—Alzheimer's disease	0.000371	0.00316	CcSEcCtD
Carbinoxamine—Nausea—Rivastigmine—Alzheimer's disease	0.000362	0.00309	CcSEcCtD
Carbinoxamine—Chlorpromazine—CALM1—Alzheimer's disease	0.000323	0.0893	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR6—Alzheimer's disease	0.000291	0.0805	CrCbGaD
Carbinoxamine—Mepyramine—CYP2D6—Alzheimer's disease	0.000283	0.0782	CrCbGaD
Carbinoxamine—Tripelennamine—CYP2D6—Alzheimer's disease	0.000261	0.0723	CrCbGaD
Carbinoxamine—Chlorphenamine—SLC6A4—Alzheimer's disease	0.000216	0.0598	CrCbGaD
Carbinoxamine—Clomipramine—SLC6A4—Alzheimer's disease	0.000162	0.0449	CrCbGaD
Carbinoxamine—Brompheniramine—CYP2D6—Alzheimer's disease	0.000155	0.0428	CrCbGaD
Carbinoxamine—Chlorphenamine—CYP2D6—Alzheimer's disease	0.000152	0.042	CrCbGaD
Carbinoxamine—Diphenhydramine—PTGS1—Alzheimer's disease	0.000151	0.0419	CrCbGaD
Carbinoxamine—Chlorpromazine—BCHE—Alzheimer's disease	0.000143	0.0395	CrCbGaD
Carbinoxamine—Clomipramine—HTR2A—Alzheimer's disease	0.000125	0.0345	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2A—Alzheimer's disease	0.000124	0.0344	CrCbGaD
Carbinoxamine—Clomipramine—CYP2D6—Alzheimer's disease	0.000114	0.0316	CrCbGaD
Carbinoxamine—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000103	0.0285	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2A—Alzheimer's disease	8.56e-05	0.0237	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP2D6—Alzheimer's disease	7.83e-05	0.0217	CrCbGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.43e-05	0.000402	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.4e-05	0.000394	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.4e-05	0.000394	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—A2M—Alzheimer's disease	1.38e-05	0.000389	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.35e-05	0.000381	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.35e-05	0.000381	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—A2M—Alzheimer's disease	1.35e-05	0.00038	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.34e-05	0.000378	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.33e-05	0.000375	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.31e-05	0.000369	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.31e-05	0.000369	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PSEN2—Alzheimer's disease	1.31e-05	0.000368	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.28e-05	0.000362	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.28e-05	0.000359	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.27e-05	0.000359	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.26e-05	0.000355	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.26e-05	0.000354	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.23e-05	0.000347	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.22e-05	0.000345	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.21e-05	0.000341	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.21e-05	0.00034	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NPY—Alzheimer's disease	1.2e-05	0.000339	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	1.2e-05	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.2e-05	0.000337	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IAPP—Alzheimer's disease	1.2e-05	0.000337	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	1.19e-05	0.000334	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.18e-05	0.000334	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.18e-05	0.000331	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.17e-05	0.000331	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.17e-05	0.000329	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.17e-05	0.000329	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.17e-05	0.000329	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.16e-05	0.000327	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.16e-05	0.000327	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CRH—Alzheimer's disease	1.16e-05	0.000327	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CCR5—Alzheimer's disease	1.15e-05	0.000322	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.13e-05	0.000318	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	1.12e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	1.12e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.12e-05	0.000316	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.12e-05	0.000316	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	0.000311	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.1e-05	0.00031	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.1e-05	0.00031	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NPS—Alzheimer's disease	1.1e-05	0.00031	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.09e-05	0.000308	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.09e-05	0.000307	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—F2—Alzheimer's disease	1.08e-05	0.000305	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.08e-05	0.000304	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	0.000304	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	1.08e-05	0.000304	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.08e-05	0.000303	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.08e-05	0.000303	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.07e-05	0.000301	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.07e-05	0.0003	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.07e-05	0.0003	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.06e-05	0.000298	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	1.05e-05	0.000296	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	1.05e-05	0.000296	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SST—Alzheimer's disease	1.05e-05	0.000296	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	1.05e-05	0.000294	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	1.05e-05	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.04e-05	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.04e-05	0.000293	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	1.04e-05	0.000293	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.03e-05	0.00029	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.02e-05	0.000288	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APP—Alzheimer's disease	1.02e-05	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.02e-05	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.02e-05	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1e-05	0.000283	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.93e-06	0.00028	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	9.87e-06	0.000278	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	9.84e-06	0.000277	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—F2—Alzheimer's disease	9.82e-06	0.000277	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.73e-06	0.000274	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	9.66e-06	0.000272	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	9.65e-06	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.64e-06	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.59e-06	0.00027	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	9.56e-06	0.000269	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	9.52e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ENO1—Alzheimer's disease	9.52e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—A2M—Alzheimer's disease	9.51e-06	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	9.37e-06	0.000264	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	9.34e-06	0.000263	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.3e-06	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.07e-06	0.000255	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	9.01e-06	0.000254	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	8.97e-06	0.000252	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	8.95e-06	0.000252	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	8.85e-06	0.000249	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	8.8e-06	0.000248	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	8.76e-06	0.000247	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.5e-06	0.000239	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.5e-06	0.000239	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.48e-06	0.000239	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	8.35e-06	0.000235	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.34e-06	0.000235	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.34e-06	0.000235	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—S100B—Alzheimer's disease	8.32e-06	0.000234	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.27e-06	0.000233	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.25e-06	0.000232	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	8.24e-06	0.000232	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	8.21e-06	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.19e-06	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.18e-06	0.00023	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	8.1e-06	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	8.07e-06	0.000227	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	8.04e-06	0.000226	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	7.92e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.9e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.82e-06	0.00022	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.82e-06	0.00022	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.75e-06	0.000218	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.75e-06	0.000218	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	7.66e-06	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	7.6e-06	0.000214	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—LPL—Alzheimer's disease	7.51e-06	0.000211	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.46e-06	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—LPL—Alzheimer's disease	7.35e-06	0.000207	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	7.34e-06	0.000207	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.31e-06	0.000206	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	7.28e-06	0.000205	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.27e-06	0.000205	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.23e-06	0.000204	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.21e-06	0.000203	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	7.14e-06	0.000201	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.04e-06	0.000198	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.04e-06	0.000198	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	6.98e-06	0.000197	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	6.95e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	6.95e-06	0.000196	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.86e-06	0.000193	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.8e-06	0.000191	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	6.76e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	6.76e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.74e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.67e-06	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.65e-06	0.000187	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	6.62e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	6.62e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.59e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.49e-06	0.000183	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LPL—Alzheimer's disease	6.35e-06	0.000179	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	6.31e-06	0.000178	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—Alzheimer's disease	6.29e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.27e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	6.23e-06	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.23e-06	0.000175	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.2e-06	0.000175	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	6.18e-06	0.000174	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	6.18e-06	0.000174	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—Alzheimer's disease	6.16e-06	0.000174	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	6.15e-06	0.000173	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	6.15e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	6.11e-06	0.000172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	6.1e-06	0.000172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	5.88e-06	0.000165	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—F2—Alzheimer's disease	5.8e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.73e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	5.72e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.7e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.68e-06	0.00016	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.68e-06	0.00016	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.67e-06	0.00016	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.65e-06	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	5.48e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.45e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.39e-06	0.000152	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INS—Alzheimer's disease	5.37e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	5.37e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	5.34e-06	0.000151	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	5.33e-06	0.00015	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—Alzheimer's disease	5.33e-06	0.00015	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	5.29e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.28e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INS—Alzheimer's disease	5.26e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INS—Alzheimer's disease	5.26e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.22e-06	0.000147	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	5.17e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.17e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.11e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.11e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.11e-06	0.000144	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	5.09e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.01e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.77e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.75e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.75e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	4.71e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.71e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.7e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.66e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	4.64e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	4.62e-06	0.00013	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	4.61e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INS—Alzheimer's disease	4.55e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.48e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.39e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.37e-06	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.35e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.35e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.33e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.33e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	4.31e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.29e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	4.22e-06	0.000119	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.14e-06	0.000117	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INS—Alzheimer's disease	4.06e-06	0.000114	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.99e-06	0.000112	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.95e-06	0.000111	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	3.91e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	3.89e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.81e-06	0.000107	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.78e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.75e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.74e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.73e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INS—Alzheimer's disease	3.7e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.65e-06	0.000103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	3.6e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	3.59e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.56e-06	0.0001	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.41e-06	9.6e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	3.32e-06	9.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.28e-06	9.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.26e-06	9.17e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.25e-06	9.14e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.07e-06	8.65e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	3.05e-06	8.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3e-06	8.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.97e-06	8.36e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.87e-06	8.08e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.86e-06	8.05e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.83e-06	7.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	2.51e-06	7.07e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.49e-06	7.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.44e-06	6.88e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	2.3e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	2.17e-06	6.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.14e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.12e-06	5.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	2.12e-06	5.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.96e-06	5.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.83e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.64e-06	4.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.51e-06	4.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.49e-06	4.2e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.85e-07	2.77e-05	CbGpPWpGaD
